FDA has now settled external pacemaker pulse generators and pacing system analyzers into distinct class II with special controls risk categories. The agency issued a final order
on April 18 that takes immediate effect.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?